MECLIZINE Drug Patent Profile
✉ Email this page to a colleague
When do Meclizine patents expire, and what generic alternatives are available?
Meclizine is a drug marketed by Invagen Pharms, Ivax Sub Teva Pharms, Nexgen Pharma Inc, Pliva, Abc Holding, Amneal Pharms, Anabolic, Ani Pharms, Aurobindo Pharma Usa, Bundy, Chartwell Rx, Epic Pharma Llc, Heritage, Jubilant Cadista, Kv Pharm, Quagen, Rising, Sandoz, Senores Pharms, Strides Pharma Intl, Superpharm, UDL, Vangard, Watson Labs, and Zydus Lifesciences. and is included in thirty-seven NDAs.
The generic ingredient in MECLIZINE is meclizine hydrochloride. There is one drug master file entry for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the meclizine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Meclizine
A generic version of MECLIZINE was approved as meclizine hydrochloride by ZYDUS LIFESCIENCES on June 23rd, 2020.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MECLIZINE?
- What are the global sales for MECLIZINE?
- What is Average Wholesale Price for MECLIZINE?
Summary for MECLIZINE
| US Patents: | 0 |
| Applicants: | 25 |
| NDAs: | 37 |
| Drug Prices: | Drug price information for MECLIZINE |
| Drug Sales Revenues: | Drug sales revenues for MECLIZINE |
| DailyMed Link: | MECLIZINE at DailyMed |
US Patents and Regulatory Information for MECLIZINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | MECLIZINE HYDROCHLORIDE | meclizine hydrochloride | TABLET;ORAL | 084843-002 | May 22, 1989 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Ivax Sub Teva Pharms | MECLIZINE HYDROCHLORIDE | meclizine hydrochloride | TABLET;ORAL | 083784-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Vangard | MECLIZINE HYDROCHLORIDE | meclizine hydrochloride | TABLET;ORAL | 087877-001 | Apr 20, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Superpharm | MECLIZINE HYDROCHLORIDE | meclizine hydrochloride | TABLET;ORAL | 089113-001 | Aug 20, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
